Essential thrombocythemia with MPL W515S mutation No … ← Essential thrombocythemia with MPL W515S mutation van der Straten L, Stege CAM, Kersting S, et al. Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL. Blood. 2023;142(13):1131-1142 →